195 related articles for article (PubMed ID: 27864706)
1. Influence of insurance status and income in anaplastic astrocytoma: an analysis of 4325 patients.
Shin JY; Yoon JK; Diaz AZ
J Neurooncol; 2017 Mar; 132(1):89-98. PubMed ID: 27864706
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy.
Shin JY; Diaz AZ
J Neurooncol; 2016 Sep; 129(3):557-565. PubMed ID: 27401155
[TBL] [Abstract][Full Text] [Related]
3. Association of Insurance and Community-Level Socioeconomic Status With Treatment and Outcome of Squamous Cell Carcinoma of the Pharynx.
Shin JY; Yoon JK; Shin AK; Blumenfeld P; Mai M; Diaz AZ
JAMA Otolaryngol Head Neck Surg; 2017 Sep; 143(9):899-907. PubMed ID: 28662244
[TBL] [Abstract][Full Text] [Related]
4. Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients.
Shin JY; Diaz AZ
J Neurooncol; 2016 Sep; 129(3):567-575. PubMed ID: 27401158
[TBL] [Abstract][Full Text] [Related]
5. Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based study.
Perry AM; Brunner AM; Zou T; McGregor KL; Amrein PC; Hobbs GS; Ballen KK; Neuberg DS; Fathi AT
Cancer; 2017 Jul; 123(13):2561-2569. PubMed ID: 28464280
[TBL] [Abstract][Full Text] [Related]
6. Treatment variation by insurance status for breast cancer patients.
Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
[TBL] [Abstract][Full Text] [Related]
7. The influence of insurance status on treatment and outcomes in oral cavity cancer: an analysis on 46,373 patients.
Shin JY; Yoon JK; Shin AK; Diaz AZ
Int J Oral Maxillofac Surg; 2018 Oct; 47(10):1250-1257. PubMed ID: 29655817
[TBL] [Abstract][Full Text] [Related]
8. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
9. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
[TBL] [Abstract][Full Text] [Related]
10. Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005.
Robbins AS; Pavluck AL; Fedewa SA; Chen AY; Ward EM
J Clin Oncol; 2009 Aug; 27(22):3627-33. PubMed ID: 19470927
[TBL] [Abstract][Full Text] [Related]
11. Disparities in survival by insurance status in patients with Hodgkin lymphoma.
Parikh RR; Grossbard ML; Green BL; Harrison LB; Yahalom J
Cancer; 2015 Oct; 121(19):3515-24. PubMed ID: 26058564
[TBL] [Abstract][Full Text] [Related]
12. Insurance status is related to diffuse large B-cell lymphoma survival.
Han X; Jemal A; Flowers CR; Sineshaw H; Nastoupil LJ; Ward E
Cancer; 2014 Apr; 120(8):1220-7. PubMed ID: 24474436
[TBL] [Abstract][Full Text] [Related]
13. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.
Rice SR; Vyfhuis MAL; Scilla KA; Burrows WM; Bhooshan N; Suntharalingam M; Edelman MJ; Feliciano J; Badiyan SN; Simone CB; Bentzen SM; Feigenberg SJ; Mohindra P
Clin Lung Cancer; 2020 May; 21(3):e130-e141. PubMed ID: 31708388
[TBL] [Abstract][Full Text] [Related]
14. The association between health insurance coverage and diabetes care; data from the 2000 Behavioral Risk Factor Surveillance System.
Nelson KM; Chapko MK; Reiber G; Boyko EJ
Health Serv Res; 2005 Apr; 40(2):361-72. PubMed ID: 15762896
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in anaplastic oligodendroglioma: An analysis on 1643 patients.
Shin JY; Yoon JK; Diaz AZ
J Clin Neurosci; 2017 Mar; 37():34-39. PubMed ID: 28024733
[TBL] [Abstract][Full Text] [Related]
16. Association Between Primary Payer Status and Survival in Patients With Stage III Colon Cancer: An National Cancer Database Analysis.
Ahmed A; Tahseen A; England E; Wolfe K; Simhachalam M; Homan T; Sitenga J; Walters RW; Silberstein PT
Clin Colorectal Cancer; 2019 Mar; 18(1):e1-e7. PubMed ID: 30297265
[TBL] [Abstract][Full Text] [Related]
17. Insurance status and level of education predict disparities in receipt of treatment and survival for anal squamous cell carcinoma.
Patel KS; Alhatem A; Gadde U; Ahlawat S; Lambert C; Schwartz RA; Dalla Piazza M
Cancer Epidemiol; 2020 Aug; 67():101723. PubMed ID: 32408241
[TBL] [Abstract][Full Text] [Related]
18. The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer.
Parikh AA; Robinson J; Zaydfudim VM; Penson D; Whiteside MA
J Surg Oncol; 2014 Sep; 110(3):227-32. PubMed ID: 24810008
[TBL] [Abstract][Full Text] [Related]
19. Insurance status and outcome after intracerebral hemorrhage: findings from Get With The Guidelines-stroke.
James ML; Grau-Sepulveda MV; Olson DM; Smith EE; Hernandez AF; Peterson ED; Schwamm LH; Bhatt DL; Fonarow GC
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):283-92. PubMed ID: 23537567
[TBL] [Abstract][Full Text] [Related]
20. Uninsurance among children whose parents are losing Medicaid coverage: Results from a statewide survey of Oregon families.
DeVoe JE; Krois L; Edlund T; Smith J; Carlson NE
Health Serv Res; 2008 Feb; 43(1 Pt 2):401-18. PubMed ID: 18199193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
